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The specificity-conferring code of adenylation domains in 
nonribosomal peptide synthetases 
Torsten Stachelhaus*, Henning D Mootz and Mohamed A Marahiel 
Background: Many pharmacologically important peptides are synthesized 
nonribosomally by multimodular peptide synthetases (NRPSs). These enzyme 
templates consist of iterated modules that, in their number and organization, 
determine the primary structure of the corresponding peptide products. At the 
core of each module is an adenylation domain that recognizes the cognate 
substrate and activates it as its aminoacyl adenylate. Recently, the crystal 
structure of the phenylalanine-activating adenylation domain PheA was solved with 
phenylalanine and AMP, illustrating the structural basis for substrate recognition. 
Results: By comparing the residues that line the phenylalanine-binding pocket in 
PheA with the corresponding moieties in other adenylation domains, general rules 
for deducing substrate specificity were developed. We tested these in silica 
‘rules’ by mutating specificity-conferring residues within PheA. The substrate 
specificity of most mutants was altered or relaxed. Generalization of the selectivity 
determinants also allowed the targeted specificity switch of an aspartate- 
activating adenylation domain, the crystal structure of which has not yet been 
solved, by introducing a single mutation. 
Conclusions: In silica studies and structure-function mutagenesis have defined 
general rules for the structural basis of substrate recognition in adenylation 
domains of NRPSs. These rules can be used to rationally alter the specificity of 
adenylation domains and to predict from the primary sequence the specificity of 
biochemically uncharacterized adenylation domains. Such efforts could enhance 
the structural diversity of peptide antibiotics such as penicillins, cyclosporins and 
vancomycins by allowing synthesis of ‘unnatural’ natural products. 
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Introduction 
Nonribosomally synthesized peptides represent a large 
group of structurally complex metabolites that are manu- 
factured from amino, hydroxy and carboxy acid monomers 
by large multifunctional enzymes, termed nonribosomal 
peptide synthetases (NRPSs) [l-4]. Although their actual 
biological roles in the producing organisms (primarily 
bacilli, actinomycetes and filamentous fungi) are often 
obscure, a remarkable variety of pharmacological proper- 
ties can be linked to such naturally occurring peptides. 
Important antibiotics synthesized by NRPSs include peni- 
cillins and cephalosporins, vancomycins, as well as the 
immunosuppressant cyclosporin A [l-3]. Interestingly, the 
same class of NRPSs also assembles several virulence- 
conferring siderophoric peptides, such as mycobactin and 
yersiniabactin [5,6]. 
Primary structure, size and complexity of a peptide product 
are dictated by the number and organization of iterated 
modules, which constitute the NRPS template [ 141. Each 
module activates its cognate amino acid in a two-step reac- 
tion using a pair of closely coupled domains. An adenyl- 
ation (A) domain selects the cognate amino acid from the 
pool of available substrates and generates the correspond- 
ing aminoacyl adenylate using ATP. The aminoacyl 
moiety is then covalently tethered to the sulfhydryl group 
of a phosphopantetheinyl (Ppant) prosthetic group on an 
adjacent thiolation domain (also called peptidyl carrier 
protein, PCP). Thiolation domains are post-translationally 
modified by Ppant transferases, which add the Ppant group 
[7]. The nascent peptidyl chain grows unidirectionally 
under the catalytic control of a condensation (C) domain 
each time an upstream peptidyl-S-Ppant donor is attacked 
by a monomeric aminoacyl-S-Ppant nucleophile [8]. Modi- 
fying the incorporated monomers (e.g. by epimerization or 
N-methylation) or the peptide backbone (e.g. by acylation, 
glycosylation or heterocylization) can further functionalize 
the synthesized peptide product. These tailoring reactions 
are catalyzed by specialized domains or by fusion to 
polyketide synthase (PKS) modules [l--3]. 
Although several biochemical studies have shown that the 
A domains are the specificity-mediating ‘gate-keeper’ 
units of the repeated modules [9-111, the selectivity- 
conferring elements have remained unclear. This has 
changed recently, with the elucidation of the crystal 
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Figure 1 
Structural basis for phenylalanine activation by 
PheA (from Conti et al. [13]). (a) The ribbon 
diagram of PheA shows how the A domain is 
folded into a large amino-terminal and a smaller 
carboxy-terminal subdomain. The AMP (red) 
and phenylalanine (orange), bound at the 
interface between both subdomains, are 
shown in space-filling presentation. The 
locations of the highly conserved core motifs 
are indicated : Al, LTYxEL; 
A2, LKAGxAWPID; 
A3, LAYxxYTSGl-TGxPKG; A4, FDxS; 
A5, NxYGPTE; A6, GELxlxGxGlARGYW; 
A7, YKTGDO; A8, GRxDxCIVKIRGx- 
RVELEEVE; A9, LPxYMIP; and Al 0, NGKIDR 
(using single-letter amino-acid code where x is 
any amino acid). (b) The phenylalanine-specific 
binding pocket consists of ten residues. 
Asp235 and Lys517 mediate electrostatic 
interactions (dotted lines) with the a-amino and 
cc-carboxylate groups of phenylalanine, 
whereas the sidechain specificity pocket is 
surrounded on one side by Ala236,lle330 and 
Cys331, and on the other side by Ala322, bottom of the pocket. This architecture allows 
Ala301, lle299 and Thr278. Both sides are PheA to accommodate L-Phe (green) and D- 
separated by the indole ring of Trp239 at the Phe with no significant change in conformation. 
structures of two members of this superfamily of adeny- 
late-forming enzymes. First, the structure of firefly 
Iuciferase of Photinuspyralis was reported [12], which con- 
firmed the existence of a third scaffold for the ATP- 
dependent formation of aminoacyl adenylates, in addition 
to those found in class I and class II aminoacyl tRNA syn- 
thetases. Subsequently, the structure of the A domain of 
the peptide synthetase GrsA (termed PheA) was solved 
complexed with phenylalanine and AMP (Figure la) [13]. 
This second structure provided, for the first time, funda- 
mental insight into the structural basis of substrate recog- 
nition and activation (Figure lb). 
Although the protein sequence similarity between PheA 
and luciferase is only 16%, both enzymes share a highly 
conserved three-dimensional structure [l&13]. As shown 
for PheA (Figure la), the enzyme folds into a large amino- 
terminal and a smaller carboxy-terminal subdomain. The 
latter has been shown to be important for catalytic activity, 
and is rotated 94” with respect to the amino-terminal sub- 
domain, when compared to the structure of luciferase. 
Because luciferase was crystallized in the absence of sub- 
strate, the rotation can be interpreted as an active conforma- 
tional change during the course of substrate recognition and 
activation. Indeed, the active site is located at the interface 
between the folding domains and rotation closes the cleft 
between them. Most of the highly conserved core motifs 
(Al to AlO, Figure la) were found surrounding the active 
site where the substrates bind. This finding confirmed pre- 
vious results obtained using site-directed mutagenesis and 
photoaffinity labeling, which indicated that these motifs are 
involved in ATP binding and hydrolysis [14-181. 
The conclusion that shared sequence motifs play a key role 
in ATP binding is reasonable, because all A domains 
require ATP as a substrate. In contrast, the residues lining 
the phenylalanine-binding pocket were found to be located 
within a 100 amino acid (aa) stretch that possesses a lower 
overall similarity between different A domains (Figure 2) 
[13]. On the strength of sequence alignments and hybrid 
domain construction [ 19-231, this area was also proposed to 
confer substrate specificity on the A domains. As shown in 
Figure lb, the a-amino and the a-carboxylate groups of the 
substrate amino acid are stabilized by electrostatic interac- 
tions with Asp’235 and Lys517, respectively. These 
residues are located in the highly conserved core motifs A4 
(Asp235) and A10 (Lys517) [1,4], with the latter being 
found in a loop within the carboxy-terminal subdomain 
(Figure la). The specificity pocket for the phenylalanine 
sidechain is bordered on one side by Ala236, Ile330 and 
Cys331, and by Ala322, Ala301, Ile299 and Thr278 on the 
other side. Both sides are appropriately separated by the 
indole ring of Trp239 at the bottom of the pocket. At one 
end, towards the viewer in Figure lb, a water-filled channel 
connects the pocket with the surrounding solvent. Inspec- 
tion of the PheA binding pocket shows that both D- and 
L-Phe can be accommodated (Figure lb) with no signifi- 
cant change in conformation [13], confirming biochemical 
data which revealed that both stereoisomers are activated 
with the same catalytic efficiency 191. 
We expected, because of the high similarity between 
peptide synthetases, that amino-acid residues that corre- 
spond to those lining the PheA binding pocket would 
likewise mediate substrate specificity in these enzymes. 
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Figure 2 
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sequences between core motifs A4 and A5 (-100 aa; see Figure 1 a) represents the signature sequence of an A domain. The signatures of 
were aligned to the corresponding sequence of PheA (top row). 160 different A domains were determined in this way. 
Knowledge of these residues, in turn, might allow engi- 
neering of the corresponding enzymes to alter or relax 
substrate specificity. The synthesis of novel peptides with 
modified biological and/or pharmacological properties 
would therefore be enabled. As a first approach to this 
goal, we determined and examined the binding pockets of 
160 other A domains. Some general rules for deducing 
substrate specificity were developed on the basis of these 
putative recognition sites. We then mutated selectivity- 
conferring residues in the PheA binding pocket to test our 
theory. Generalization of selectivity determinants allowed 
us to specifically alter the substrate specificity of an aspar- 
tate-activating A domain whose crystal structure has not 
yet been solved. 
Results and discussion 
Previous studies predicted that the substrate specificity of 
NRPS A domains is determined by a 200 aa stretch com- 
prising the core motifs A3 to A6 [19-231. This segment has 
a lower overall similarity among different A domains 
(Figure 2), but it was assumed that the similarity between 
domains activating the same substrate should be signifi- 
cantly higher. Consequently, such domains should cluster 
together in a phylogenetic tree. This assumption was only 
modestly confirmed, because the determination of an 
ancestral relationship was significantly impaired by the 
influence of sequence origin [23]. This problem was partially 
overcome by further shortening the A domain sequences, 
but even in these cases the evolutionary relationship was 
still a substantial factor. A genuine grouping according to 
substrate specificity was observed only for highly related 
domains that probably descended from the same ancestor. 
Determination of putative substrate-binding pockets 
We began by examining luciferase and PheA, which, 
although only 16% similar in terms of their primary struc- 
ture, share a highly conserved three-dimensional structure 
(Figure la) [13]. A structurally based sequence alignment 
revealed that 67% of the a-carbons of both enzymes are 0 
separated by less than 3 A. Considering the much more 
pronounced similarity between PheA and other NRPS 
A domains (between 26% and 56%) [l], the conformation 
of their mainchains is likely to be very similar too. Substrate 
specificity should therefore be mediated by the nature of 
the residues lining the PheA binding pocket (Figures lb 
and 2). Put another way, the solved structure of PheA (and 
luciferase) can be considered precedents for the entire 
superfamily of adenylating enzymes, and sequence com- 
parisons should allow the constituents of the binding 
pockets of all other A domains to be determined (Figure 2). 
For our initial alignments, we examined the -100 aa 
stretch between core motifs A4 and A5 (Figure 2) that 
contains nine of the ten constituents of the PheA binding 
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pocket (the missing residue is the highly conserved 
Lys517, core motif AlO, which is located in a loop within 
the carboxy-terminal subfolding domain) [13]. The 
sequences of 160 A domains were retrieved from publicly 
accessible databases and aligned using the program 
MegAlign from the DNAStar package (see the Materials 
and methods section). Assessment of each constituent of 
the proposed binding pockets was assisted by the pres- 
ence of adjacent (within 2 aa residues), highly conserved 
sequence motifs (A4 and AS, as well as the two unnamed 
motifs ‘TPS’ and ‘GE’) [l], which presumably ‘anchor’ 
these moieties within the tertiary structure (Figure 2). 
All sequences were then trimmed down to the con- 
stituents of their presumed binding pockets, and new 
sequence alignments and phylogenetic studies were per- 
formed considering only these ten residues (Figures 2,3). 
We postulated that if these extracted moieties represent 
the codon (signature sequence) of substrate specificity, 
then the domains that recognize the same substrate 
should cluster together in a phylogenetic tree. As shown in 
Figure 3, this novel alignment indeed revealed a cluster- 
ing of A domains according to their specificity that is only 
slightly affected by sequence origin. In contrast to previ- 
ous phylogenetic studies, bacterial and fungal sequences 
are not separated because of their evolutionary distances, 
but are found scattered over all three main branches 
(Figure 3). This outcome indicates that the overall 
concept of their structural homology is correct, and that 
the selected residues represent the signature for the 
recognition of the cognate amino acid substrate. These 
results can even explain some discrepancies between pos- 
tulated and observed specificities, and should permit sub- 
strates of newly discovered domains to be predicted, some 
examples of which are shown in red boxes in Figure 3. 
First, Phe(TycB2) does not cluster with Phe domains, but 
rather with domains that activate other aromatic sub- 
strates. In fact, it was observed that, although this domain 
can activate phenylalanine, the preferred substrate of this 
domain is tryptophan [lo]. Second, the molecular charac- 
terization of a NRPS template from Badus licdenzjbrmis 
ATCC 10716 shared highest similarity (97%) with a puta- 
tive lichenysin A synthetase operon from B. l’ichenifonnis 
BNPZ9 [24,25]. Consequently, an asparagine specificity 
was proposed for the fifth module, LicBZ (and LchABZ), 
of the biosynthetic template. The signature sequences of 
these A domains match the consensus sequence of aspar- 
tate rather than asparagine domains (especially the key 
residue His322), however, as we will demonstrate below. 
Recently, the recombinant LicBZ A domain was indeed 
shown to activate ~-Asp, but not L-Asn [Z]. Third, the 
binding pocket of an A domain from an as yet uncharacter- 
ized peptide synthetase from Mycobactetium tuberculosis 
clusters and exactly matches the signature sequence of 
several phenylalanine-activating domains [26]. Fourth, 
sequencing and analysis of the genes involved in the 
Fiaure 3 
A Domain signature sequences were used to construct a phylogenetic 
tree, which shows that the signatures cluster according to their domain 
specificity (yellow boxes). Examples are shown which demonstrate that 
the substrate specificity of newly discovered domains can be 
predicted, and that the observed rather than the postulated specificity 
(red boxes) determine the clustering (see examples in the text). This is 
also true for the mutants PheA(Thr278-+Met/Ala301 +Gly) and 
AspA(His322+Glu) (green boxes), which are specific for leucine and 
asparagine, respectively, in ATP-pyrophosphate exchange assays. 
biosynthesis of the vancomycin group antibiotic chloroere- 
momycin from Amycolatopsis orientalis revealed the pres- 
ence of an additional peptide synthetase, Orf19, that was 
not addressed further in the original report [27]. The sig- 
nature sequence of this open reading frame clusters with 
tyrosine domains and it can therefore be postulated that 
Orf19 is involved in the synthesis of the unusual tyrosine- 
based precursors recognized and incorporated by chloroer- 
emomycin synthetases. This hypothesis is sustained by 
the presence of adjacent putative hydroxylases or haloper- 
oxidases [27]. This is an example of how substrate predic- 
tions can support hypotheses regarding uncharacterized 
biosynthetic pathways. 
Up until now, the only way to identify the specificity of an 
unknown adenylating enzyme was biochemical characteri- 
zation using the ATP-pyrophosphate exchange assay. 
Because previous attempts to assess A domain specificity 
directly from their primary sequence (using the 200 aa 
stretch between A3 and A6) were only 43% accurate [19], 
accurate predictions of NRPS module specificity were not 
permitted using sequence homology alone [28]. However, 
the new phylogenetic approach (using only the ten 
binding-pocket constituents shown in Figures 2 and 3) is 
86% accurate (only 22 of 160 sequences surveyed are 
unmatched), and the true accuracy appears to be even 
higher (92%), because nine unmatched sequences repre- 
sent single examples for unique substrates. In conclusion, 
for many biosynthetic systems the reliability of such pre- 
dictions is already very high. For other systems, particu- 
larly in cases of organisms where only a few domains have 
been sequenced, it will further improve with expansion of 
available sequence data. 
The specificity-conferring code of A domains 
From clusters of domains activating the same substrate 
(Figure 3), the consensus sequences of various substrate- 
binding pockets can be determined (Table 1). These signa- 
ture sequences can be interpreted as the ‘code’ of NRPSs 
[29], and, as is true for the well known ribosomal prece- 
dent, this code appears to be degenerate. For instance, at 
least four different signature sequences were defined for 
leucine-activating domains, three for valine and two for cys- 
teine (Table l), and we anticipate that multiple strategies 
also exist for other substrates. 
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Table 1 
The selectivity-conferring code of A domains. 
Position 
Domain 235 236 239 278 299 301 322 330 331 517 Biosynthetic template Similarity 
Aad E P 
Ala D L 
Asn D L 
Asp D L 
Cydl) D H 
Cys@) D L 
Dab D L 
DhblSal P L 
Gln D A 
Glu(1) D A 
Glu(2) D A 
Ile (1) D G 
Ile (2) D A 
Leu(1) D A 
Leu(2) D A 
Leu(3) D G 
Leu(4) D A 
Orn(1) D M 
Orn(2) D V 
Phe D A 
Phg/hPhg D I 
Pip/Pip-@ D F 
Pro D V 
Ser D V 
ThrlDht D F 
Tyr(l) D G 
Tyr(2) D A 
Tyr(3) D A 
Val(1) D A 
Val(2) D F 
Val(3) D A 
Variability 30/, 1 6% 
R 
L 
T  
T  
E 
Y 
E 
P 
a 
W 
K 
F 
F 
W 
W 
A 
F 
E 
G 
W 
F 
a 
cl 
W 
W 
T  
L 
S 
F 
E 
W 
1 6% 
N 
F 
K 
K 
S 
N 
H 
A 
D 
H 
D 
F 
F 
F 
L 
Y 
M 
N 
E 
T  
L 
L 
L 
H 
N 
I 
V 
T  
W 
S 
M 
39% 
I 
G 
L 
V 
D 
L 
N 
a 
L 
F 
L 
L 
Y 
L 
Y 
T  
L 
L 
I 
I 
L 
L 
I 
L 
I 
T  
T  
V 
I 
T  
F 
52% 
V 
I 
G 
G 
V 
S 
T  
G 
G 
G 
z 
G 
G 
G 
G 
G 
G 
G 
A 
G 
G 
A 
S 
G 
A 
G 
A 
G 
A 
A 
I 30/, 
E 
A 
E 
: 
L 
T  
V 
V 
G 
V 
V 
I 
N 
A 
E 
M 
L 
S 
A 
L 
V 
H 
L 
M 
E 
A 
A 
G 
A 
A 
26% 
F 
V 
V 
I 
I 
I 
V 
V 
V 
V 
V 
V 
T  
V 
V 
V 
V 
I 
I 
V 
L 
A 
V 
I 
V 
V 
V 
V 
T  
V 
V 
23% 
V 
L 
G 
G 
T  
W 
S 
N 
D 
D 
D 
Y 
F 
V 
M 
V 
F 
N 
D 
C 
C 
V 
V 
D 
H 
A 
V 
C 
F 
Y 
L 
26% 
K AcvA 94% 
K CssA, Htsl 55% 
K BacA, CepA, Dae, Glgl , TycC 900/o 
K BacC, SrfAB, LicB, LchAB 100% 
K AcvA 96% 
K BacA, HMWPP 88% 
K SyrE 100% 
K EntE, DhbE, MbtA, PchD, VibE, YbtE 83% 
K LicA, LchAA 100% 
K FenA, FenC, FenE, PPSl , PPSB, PPS4 95% 
K BacC, SrfAA 95% 
K BacA, BacC, LicC, LchAC 92% 
K FenB, PPS5 100% 
K BacA, LicA, LchAA, LicB, LchAB, SrfAA, SrfAB 990/o 
K CssA 1ooo/o 
K GrsB, TycC 100% 
K LicA, LchAA, SrfAA 97% 
K FxbC 1 000/o 
K BacB, FenC, GrsB, PPSl , TycC 98% 
K GrsA, SnbDE, TycA, TycB 88% 
K CepB, CepC, SnbDE 80% 
K FkbP, RapP, SnbA, SnbDE 75% 
K GrsB, FenA, PPS4, SnbDE, TycB 870/o 
K EntF, SyrE 90% 
K AcmB, Fxb, PPS2, PyoD, SnbC, SyrB, SyrE 91% 
K FenA, PPSP, PPS4 100% 
K TycB, TycC 800/o 
K BacC, CepA, CepB 78% 
K GrsB, FenE, LicB, LchAB, PPSS, SrfAB, TycC 96% 
K AcvA 94% 
K CssA 95% 
0% Wobble-like poshons 
This table complements Figure 3. From clusters of signature 
sequences derived from domains activating the same substrate, the 
consensus sequences for the recognition of various substrates were 
determined. The biosynthetic templates of origin and the overall 
similarity of signature sequences, which were integrated into a codon, 
are depicted. Variable constituents within a codon are shown (red), 
The signature sequences determined could now be pro- 
jected onto the crystal structure of PheA, in order to esti- 
mate the general appearance of putative substrate-binding 
pockets. As examples, Figure 4 shows the estimated shape 
of the binding and recognition sites of three different sub- 
strates: the acidic aspartate, the basic ornithine and the 
hydrophobic valine. Although Asp235 and Lys517 are 
highly conserved in all amino-acid-activating domains 
(mediating key interactions with the amino and the car- 
boxy1 groups of the substrate), all of the other residues are 
believed to determine the specific shape of the pocket 
and facilitate the recognition of the substrate sidechain 
[13]. In all three examples, the remaining residues support 
this assumption, as they complement the polarity of the 
recognized substrate (compare with Figure ‘2 for the deter- 
mination of the putative binding pocket constituents). In 
aspartate activation (signature sequence ‘Asp’) the basic 
and proposed ‘wobble’-like positions, revealing an elevated variability 
throughout all codons determined (2 36%), are indicated in cyan. Aad, 
G(L-a-aminoadipic acid); Dab, 2,3-diamino butyric acid; Dhb, 
2,3-dihydroxy benzoic acid; Sal, salicylate; Phg, L-phenylglycine; hPhg, 
4-hydroxy-L-phenylglycine; Pip, L-pipecolinic acid; Dht, 
dehydrothreonine; @ indicates a modification of the residue. 
His322 (perhaps secondarily also Lys278) facilitates the 
key interaction with the acidic sidechain, whereas the 
large sidechain of Leu236 probably closes the pocket 
underneath against larger substrates. In ornithine activa- 
tion (signature sequence ‘Orn(2)‘) the acidic Glu278 and 
Asp331 seem to be the key players for the recognition of 
the large, basic sidechain. In valine activation (signature 
sequence ‘Val(3)‘) the entire binding pocket for the 
hydrophobic substrate is assembled by hydrophobic 
residues. The bulkiness of the substrate caused by its 
p branching is taken into account by the exclusive use of 
alanine moieties in positions 236,301 and 322 in the upper 
portion of the pocket and bulky residues at the bottom, 
which keep the two sides of the binding pocket apart. 
Another similarity between the ribosomal and nonriboso- 
ma1 codes, besides degeneracy, is the presence of flexible 
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Figure 4 
Chemistry & Biology 
A simplified representation of the proposed binding pockets of three A 
domains. The putative binding pocket constituents of (a) an aspartate- 
activating domain (SrfABP), (b) an ornithine-activating domain (GrsB3) 
and (c) a valine-activating domain (CssAS), determined in Figure 2, 
were projected onto the binding pocket of PheA shown in Figure 1 b. 
The assessed aliphatic (blue), polar (yellow), acidic (red) and basic 
(green) sidechains are shown schematically. In all cases, Asp235 and 
Lys517 mediate key interactions with the a-amino and a-carboxylate 
group of the substrate, and all other residues facilitate recognition of 
the substrate sidechains and (ideally) complement the polarity of the 
recognized substrate. 
positions within certain signature sequences. As shown in 
Table 1, residues 278 and 299 can be thought of as 
‘wobble’-like positions that are highly variable throughout 
the signature sequences. Moreover, because nonribosomal 
‘codons’ consist of ten residues, some other positions also 
show flexibility. Generally binding pockets that recognize 
small amino acids have more flexibility in positions close 
to the bottom of the binding pocket, whereas for larger 
substrates, positions in the top portion are a little bit more 
imprecise (Table 1). 
Variability of binding-pocket constituents provides 
evidence for specificity-conferring key positions 
The examples outlined above further strengthen the 
hypothesis that sequence comparisons with PheA allow the 
constituents of the binding pockets of other A domains to 
be determined. Furthermore, the studies summarized in 
Table 1 and Figure 4 imply varied significance for differ- 
ent positions within a binding pocket for the mediation of 
substrate selectivity. To verify this observation, we took a 
closer look at the constituent amino acids of 160 speci- 
ficity-conferring signature sequences (Figure 5). According 
to their variability the sidechains were classified into three 
subgroups: ‘invariant’ residues (positions 235 and 517), 
‘moderately variant’ (aliphatic) residues (positions 236, 301 
and 330), and ‘highly variant’ residues (positions 239, 278, 
299, 322 and 331). Taking into account that a meaningful 
link between amino-acid usage and substrate polarity can 
be observed only for the highly variant residues, the high 
variability probably reflects their importance in contribut- 
ing to substrate specificity. 
invariant residues 
Of the invariant residues, Asp235 stabilizes the a-amino 
group of the substrate and is therefore essential (except in 
domains that do not have an a-amino group - that is the 
a-aminoadipate activating domains of AcvA synthetases 
and carboxy-/hydroxy-acid-activating domains, such as 
luciferase, EntF and YbtE). Lys517 is strictly invariant 
and pairs with the a-carboxylate of the substrate as well as 
the O-4’ and O-S’ of the ATP/AMP ribose moiety, pre- 
sumably fixing their positions in the active site and clamp- 
ing the carboxy-terminal folding domain in an active 
conformation. Both residues therefore mediate key inter- 
actions with the a-amino and a-carboxylate group of the 
substrate (and not the sidechain; see Figures 1 b and 3). 
Moderately variant (aliphatic) residues 
The residues in positions 236, 301 and 330 vary only 
slightly throughout all binding pockets, and the vast major- 
ity of A domains (93% of 160 domains surveyed) use 
aliphatic sidechains in these positions. Taking into account 
the low overall variability and the under-representation of 
charged or polar sidechains, it is very unlikely that these 
residues are the major elements for the discrimination and 
selection of different substrates. As we demonstrate below, 
however, these positions might modulate the catalytic activ- 
ity (V,,,) and fine-tune the specificity of the corresponding 
domains. It should be noted that this observation is incon- 
sistent with previous predictions made in the cyclosporin 
system, which specified that two of these three residues 
provide the greatest discrimination and selectivity for dif- 
ferent substrates [Zl]. We will discuss this point below. 
500 Chemistry & Biology 1999, Vol 6 No 8 
Figure 5 
No. of aa used Hydrophobic 
No. of aa used Hydrophobic Polar Acidic Basic Position 331 
No. of aa used Hydrophobic Polar 
No. of aa used Hydrophobic 
13 59% 24% 11% 6% 16 41% 36% 7% 16% 
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Observed variations of amino acids that constitute substrate-binding data, the ten constituent amino acids can be classified into three 
pockets. The proposed signature sequences from 160 different subgroups. Positions 235 (aspartate: acidic, red) and 517 (lysine: 
A domains were investigated (compare with Figure 2). The proportional basic, green) are considered ‘invariant’. Positions 236,301 and 330 are 
distribution of the nature of their substrates is shown in the lower table. only ‘moderately variant’. The vast majority (93%) of the A domains 
The yellow table linked to each position displays the number of different examined use hydrophobic sidechains in these positions (blue). ‘Highly 
amino acids found in that position, and the proportional occurrence of variant’ are the residues at positions 239, 278, 299,322 and 331 
hydrophobic, polar, acidic and basic sidechains. According to these (gray), which reveal the highest variability of amino-acid usage. 
Highly variant residues 
The residues in positions 239, 278, 299,322 and 331 show 
the highest flexibility with respect to amino-acid usage. 
Apart from positions 278 and 299, which are generally very 
adaptable (‘wobble’-like), we predict that they facilitate 
substrate specificity. Considering their relative localization 
within the binding pocket, and taking into account the 
data shown in Table 1, as well as Figure 4, one can assume 
that position 322 possesses a higher impact for smaller 
substrates, and positions 239 and 278 for larger substrates. 
This hypothesis is supported by the consensus sequences 
for aspartate (His322), glutamate (Lys239) and ornithine 
(Glu278) activating domains, where amino acid usage and 
substrate polarity appear to be perfectly linked (Table 1). 
Mutational investigation of the PheA binding pocket 
With all the assumptions from the in s&o studies in 
mind, we set out to experimentally evaluate our predic- 
tions. First, we mutated several selectivity-conferring 
residues of the PheA binding pocket, and investigated 
the mutants for changes in the rate of ATP-pyrophos- 
phate exchange (enzyme activity) and the activation of 
miscognate amino acid substrates (enzyme specificity). 
It should be noted that wild-type PheA possesses a sig- 
nificant side-specificity for the miscognate substrates 
tryptophan (18%) and leucine (7%) [9]. The results of 
these studies are summarized in Table 2 and can be gen- 
eralized as follows. First, substitutions with slightly 
larger residues reduce the space within the pocket. 
Accordingly the ATP-pyrophosphate exchange rate of 
those mutants decreased, whereas their specificity for 
the cognate phenylalanine substrate increased (e.g. 
Thr278+Met, Thr278-+Gln, Ala301+Val, Ala322+Ser 
and Cys331+Leu). In all these cases, the side-sqectiv- 
ity for the miscognate substrates tryptophan and lehcine 
decreased by a factor of 220. Second, exactly the oppo- 
site was observed when slightly smaller residues were 
substituted, which increases the available space within 
the binding pocket. In those cases the phenylalanine- 
specific catalytic activity could be restored, whereas the 
ability to discriminate between phenylalanine and tryp- 
tophan/leucine relaxed by a factor of I5 (e.g. 
Ala301+Gly, Ala322+Gly and Ile330+Val). Third, 
mutation of the ‘highly variant’ residues (positions 239, 
278, 322 and 331) caused an up to fivefold drop in 
enzyme activity (e.g. Trp239+Leu, Thr278+Met and 
Cys331+Leu). Moreover, the introduction of charged 
(or polar) sidechains changed the polarity of the binding 
pocket and led to inactive enzymes (e.g. Ala322+Asp, 
Ala322+Lys and Ala322+Asn). Fourth, in several cases 
the observed increase in activation of a certain miscog- 
nate substrate was predictable. For example, the PheA 
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Table 2 
Activity and specificity of PheA mutants. 
Substrate 
Mutant Activity (o/o; wt = 100) 
PheA (wild type) 100 
PheA(A236L) nd 
PheA(W23QG) 3 
PheA(W239L) 20 
PheA(T276M) 32 
PheA(T278CI) 39 
PheA(l299T) 68 
PheA(A301 G) 100 
PheA(A301 V) 77 
PheA(A322D) nd 
PheA(A332E) nd 
PheA(A332G) 100 
PheA(A322l) nd 
PheA(A322K) nd 
PheA(A322N) nd 
PheA(A322Q) 1 
PheA(A322S) 30 
PheA(l330V) 95 
PheA(C33 1 L) 26 
Cognate 
L-Phe/p-Phe 
nd 
L-Phe 
L-Phelp-Phe 
L-Phe/o-Phe 
L-Phe/n-Phe 
L-Phe/o-Phe 
L-Phelp-Phe 
L-Phe/o-Phe 
nd 
nd 
L-Phe/o-Phe 
nd 
nd 
nd 
Thr/Orn 
t.-Phe/o-Phe 
L-Phe/D-Phe 
L-Phe/p-Phe 
Miscognate 
Trp (16) Leu (7) 
nd 
o-Phe (55) Val (10) 
Ile (12) Val (10) 
Leu (21) 
none 
none 
Trp (22) Leu (15) 
none 
nd 
nd 
Trp (20) Leu (10) 
nd 
nd 
nd 
nd 
Leu (17) 
Trp W), Tyr (1) 
None 
Comments 
Wild type 
Insoluble 
Almost inactive 
Met278 in Leu(1) codon 
No miscognate aa 
No miscognate aa 
Gly301 in all Leu codons 
No miscognate aa 
Inactive 
Inactive 
Inactive 
Inactive 
Inactive 
Almost inactive 
Val330 in Trp/Tyr codons 
No miscognate aa 
nd, not determined. 
(Ile330+Val) mutant had almost wild-type activity and 
specificity for phenylalanine, but had an enhanced 
ability to activate the miscognate substrates tryptophan 
and tyrosine). Interestingly, all known tryptophan/tyro- 
sine-activating A domains carry a valine in this position. 
A similar consensus was found for mutations towards a 
‘Leu(4)’ codon (Table 1). 
The signature sequences of ‘Phe’ and ‘Leu(4)’ (Table 1) 
share -60% similarity, and the main differences involve 
positions 278, 301 and 322 (note: two out of the three are 
highly variant). Therefore, single substitutions in PheA 
towards ‘Leu(4)’ (Thr278+Met and Ala301+Gly) were 
predicted and found to enhance the activation of leucine 
(Table 2). Interestingly, for PheA(Thr278+Met), the 
catalytic efficiency for the side-specific activation of 
L-Leu remained unchanged (same V,,,), whereas the 
catalytic activity for the activation of the cognate sub- 
strates (D- and L-Phe) suffered a threefold drop. In con- 
trast, in the case of PheA(Ala301+Gly), the V,,, for the 
activation of phenylalanine did not change, whereas the 
catalytic efficiency for the activation of the miscognate 
L-Leu experienced a twofold increase. All changes 
observed were significantly above the background level. 
How only three differences facilitate discrimination 
between phenylalanine and leucine is not yet known, 
but at least for position 301 one can assume that this 
residue discriminates against the bulkiness of CH 
(phenylalanine) versus CH, (leucine) moieties in the 
&position of the particular substrate sidechain. All 
A domains that activate substrates with bulky y- or 
&positions have the smallest possible sidechain (glycine) 
in position 301 (Table 2). 
Targeted alteration of the substrate specificity of PheA 
In order to alter the substrate specificity of PheA to 
leucine, we constructed the double mutant PheA 
(Thr278+Met/Ala301+Gly). The signature sequence of 
this construct is about 80% similar to ‘Leu(4)’ (Table 1) 
and clusters in the phylogenetic tree close to leucine-acti- 
vating domains (Figure 3; green box). In accordance with 
our predictions, we expected that the double mutant 
would activate leucine rather than phenylalanine. As 
shown in Figure 6a, this construct in fact preferentially 
activated L-Leu with a catalytic efficiency approaching or 
even exceeding that of the corresponding wild-type 
enzyme (mutant activity for L-Leu: k,JK, = 86 mM-l 
min-l, wild-type activity for L-Phe: 69 mM-l min-‘; 
Table 3). The minimal gain in L-Leu-specific activation 
efficiency was estimated to be about 30-fold. Surpris- 
ingly, the mutant was only slightly impaired in the activa- 
tion of D-Phe, whereas the catalytic efficiency for the 
activation of the other stereoisomer, L-Phe, sustained a 
significant sevenfold loss (Figure 6a and Table 3). For 
wild-type PheA, in contrast, it has been shown that the 
polar interactions between the protein and both ligands, 
D- and L-Phe, are almost identical [13]. The benzyl ring 
of the D-Phe sidechain is rotated by about 30” relative to 
the L-Phe ring, which leads to a marginal displacement of 
the relative position of the p carbon, but not the 0: carbon. 
Further investigations (i.e. solving the crystal structure) 
will be required to explain the observed activation 
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Figure 6 
Targeted alteration of the substrate specificity 
of PheA and AspA. The specificity of wild-type 
(green) and mutant (red, orange and blue) 
proteins was investigated using the ATP- 
pyrophosphate exchange assay. The applied 
substrates are shown on the x axis, and the 
maximum value obtained for each protein was 
set to 100%. (a) In PheA, single substitutions 
towards the ‘Leu(4)’ codon (Thr278-+Met and 
Ala301 +Gly) modestly increased the 
specificity for leucine, although the preferred 
substrate was still phenylalanine. The 
corresponding double mutant, however, 
preferentially activated leucine with a catalytic 
efficiency approaching that of wild-type PheA. 
(b) A single His322+Glu mutation in AspA 
was sufficient to completely alter the substrate 
specificity of the mutant protein from aspartate 
to asparagine. The observed activation pattern 
of the mutants coincides with the appearance 
of their signature sequences in the phylogenetic 
tree shown in Figure 3 (green boxes). 
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pattern (L-Leu > D-Phe >> L-Phe) of the double mutant 
PheA(ThrZ78+Met/Ala3Ol+Gly). 
Targeted alteration of the substrate specificity of an 
aspartate-activating domain 
To further examine our ideas about specificity predictions 
and the impact of the ‘highly variant’ residues 239,278 and 
322 as selectivity-conferring key positions, we attempted 
to alter the substrate specificity of an A domain whose 
crystal structure has not yet been solved. First, we noted 
that the signature sequences for aspartate- and asparagine- 
activating domains are very similar (80%; Table l), and the 
two major differences involve positions 322 (histidine 
versus glutamate; a highly variant residue) and 330 (valine 
versus isoleucine; a moderately variant residue). We chose 
the aspartate-activating A domain from the well-character- 
ized surfactin biosynthetic complex [22,30-321, and tried to 
alter its specificity to asparagine. The wild-type AspA con- 
struct was shown to specifically activate ~-Asp, but not 
L-Asn, with moderate activity (k,,,/K, = 10 mM-l min-l; 
Figure 6b and Table 3). In contrast, the single mutant 
AspA(His322+Glu) demonstrated a high selectivity for 
L-Asn (Figure 6b), although suffering an about tenfold loss 
of catalytic efficiency (k,,,/K, = 1 mM-1 min-‘; Table 3). 
Thus, for the mutant AspA(His322+Glu), a complete 
switch in specificity was accomplished by changing a single 
amino-acid residue. So far, the minimal gain in L-Asn-spe- 
cifrc activation efficiency was estimated to be about 
70-fold. We postulate that an additional Ile330+Val muta- 
tion might further modulate and improve the catalytic 
activity of the (now) asparagine-specific A domain. Lastly, 
AspA(H32Z-+Glu) also displayed a fivefold increase in the 
activation efficiency of isoleucine, leucine and valine. 
Do these results conflict with previous observations? 
The experimental data presented are in very good agree- 
ment with the computer predictions, and support the postu- 
lates made about the relevance of ‘moderately variant’ and 
‘highly variant’ positions for substrate discrimination and 
selectivity. However, independent in si& studies on 
cyclosporin synthetase (CssA), carried out without knowl- 
edge of the PheA structure, predicted two ‘moderately 
variant’ residues (positions 236 and 301) and only one 
‘highly variant’ residue (position 331) as having the largest 
impact on the selection of the cognate substrate [Zl]. Only 
the eleven domains of the cyclosporin synthetase (and 
some mutants) were considered, and the corresponding 
alignments were searched with restrictive criteria to identify 
key residues involved in recognizing an amino-acid sub- 
strate [Zl]. For example, an amino acid residue at a given 
position was required to be identical for domains activating 
the same substrate, and different from amino acids in all 
other domains. As shown in Table 1, this does not necessar- 
ily have to be the case. Identification of another highly 
variant residue was missed, because the same amino acid 
(methionine) is present at the same position (278) in valine- 
and glycine-activating CssA domains. 
The three residues identified by Husi et al [Zl] do not dis- 
agree with our conclusion. On the contrary, their results 
can be explained using the general rules determined for 
the deduction of substrate specificity in A domains. As 
indicated by their proximity in the phylogenetic tree 
(Figure 3), most signature sequences of CssA domains 
(valine, leucine and Bmt [(4R)-(4E)-Z-butenyl-4-methyl- 
L-threonine]; Table 1) are very similar. They probably 
descended from the same ancestor, and therefore represent 
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Table 3 
Catalytic efficiency of wild-type and mutant enzymes. 
Protein Substrate 
kat 
(min-I) 
PheA (wt) 
PheA 
(T278MIA301 G) 
Asp (ti) 
AspA(H322E) 
L-Phe 0.9 62 
D-Phe 0.9 65 
L-Leu nd nd 
L-Phe 5.2 58 
D-Phe 1.4 57 
L-Leu 0.7 60 
~-Asp 2.9 29 
L-Asn nd nd 
~-Asp nd nd 
L-Asn 27.6 30 
bdK, 
(mM-l min-I) 
69 
72 
nd 
11 
41 
86 
10 
nd 
nd 
nd, not determined. 
a nice example of how a few subtle mutations within the 
constituent residues of a binding pocket can alter substrate 
specificity. For example, the signatures for valine and 
leucine selection in CssA employ similar strategies for rec- 
ognizing their cognate, aliphatic substrates and differ only 
in two positions (position 278, methionine versus leucine, 
and position 301, alanine versus glycine; Table 1). Based 
on the mutational analysis of PheA, one would expect that 
valine and leucine domains could activate both substrates 
(leucine and valine) but with different catalytic efficien- 
cies. The finding that all CssA domains exhibit a signifi- 
cant activation of miscognate amino acids, which actually 
causes the formation of several minor cyclosporin A (CsA) 
derivatives, supports this hypothesis [33]. The composition 
of the immunosuppressant undecapeptide can be readily 
altered by increasing the concentration of a miscognate 
amino acid both in aivo and in U&J [34,35]. 
Limitations 
Comprehensive computational studies allowed us to 
establish some general rules for the determination and 
prediction of A domain selectivities. Some limitations 
should be noted, however. First, predictions of substrate 
specificities might be impeded by the limited amount of 
sequence information available. As shown in Figure 3, the 
signature sequences for recognizing several substrates are 
currently unprecedented (e.g. glycine, histidine and 
lysine). Besides, NRPSs are not restricted to proteino- 
genie substrates, and more than 300 different compounds 
are known to be incorporated into nonribosomally synthe- 
sized peptides. The facet of known substrates encom- 
passes amino, hydroxy and carboxy acids, and many of the 
corresponding signatures for recognizing such ‘unusual’ 
substrates are presently unduplicated as well (e.g. 
L-a-aminobutyric acid, Abu, Bmt, and D-a-hydroxyl isova- 
leric acid, Hiv). Second, specificity-conferring selection 
rules in a newly discovered system could be quite differ- 
ent from known A domains, and an accurate forecast could 
fail due to insufficient baseline data. For instance, only a 
few sequence and biochemical data sets are presently 
available from streptomycete NRPSs, although these 
organisms are recognized as prolific sources of secondary 
metabolites. Third, phylogenetic studies can give only a 
hint of a presumed substrate, and this indication has to be 
proven (at least) by evaluation of the amino acid usage in 
the signature sequence and, if possible, comparison with 
known NRPS codons. For example, as presented in this 
study, only by considering their signature sequences 
(especially position 322) is a differentiation between 
asparagine and aspartate domains possible. 
We anticipate that future efforts in sequencing and bio- 
chemical characterization of novel NRPS systems will 
greatly improve the reliability of any kind of prediction. 
Significance 
We present here the deciphering of the specificity-confer- 
ring code used by adenylation domains of nonribosomal 
peptide synthetases (NRPSs). These enzymes catalyze 
the biosynthesis of small, bioactive peptides, many of 
which are pharmaceutically important [l-31. The 
remarkable structural diversity of these low molecular 
weight compounds results from their being manufac- 
tured from amino, hydroxy and carboxy acid monomers. 
The sites of a multifunctional NFCPS template that select 
and activate these substrates are adenylation domains, 
the specificity of which thus dictates the composition of 
the corresponding peptide product. 
By comparing the sequence of PheA, the structure of 
which is known, with the sequences of 160 other adeny- 
lation domains, the ten residues that (putatively) form 
their amino-acid-binding pockets were identified. From 
groups of domains activating the same substrate the sig- 
nature sequences (‘codons’) for different substrate 
specificities were determined. Paralleling the genetic 
code, the NRPS selectivity-conferring code features 
redundancy (e.g. there are two signature sequences for 
cysteine and four for leucine). We expect that accumulat- 
ing sequence and biochemical data will result in discov- 
ering additional signatures for given specificities. 
Using the rules, which connect signature sequence and 
amino-acid specificity, we were able to predict from 
primary sequences the substrates of several uncharacter- 
ized or unknown adenylation domains. In the future, 
such predictions should help to circumvent the trouble- 
some biochemical characterizations of newly discovered 
NRF’S clusters of unknown function (e.g. those being 
uncovered by whole genome sequencing projects). 
Finally, the reliability and generalizability of the signa- 
ture sequences was demonstrated. Mutations in all posi- 
tions of the binding pocket of PheA were shown to alter 
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or relax its substrate specificity. By introducing two 
mutations guided by a signature sequence of leucine, the 
selectivity of PheA could be converted to leucine. Like- 
wise, a single mutation in an aspartate-activating domain 
was predicted and shown to alter the specitity to 
asparagine. These results could enable us to rationally 
alter the primary structure of pharmacologically impor- 
tant peptide antibiotics such as penicillins, cyclosporins 
and vancomycins, simply by site-directed mutation of 
their adenylation domains. In addition to broadening the 
heterogeneity of a natural product, reducing a secondary 
side-specificity might also be desirable. Engineering of 
the corresponding substrate recognition sites could 
reduce undesired byproducts produced during the large- 
scale industrial production of naturally occurring com- 
pounds (e.g. cyclosporin A and vancomycin). 
Materials and methods 
PCR amplification and cloning of PheA and AspA mutants 
All PheA mutants were constructed by site-directed mutagenesis of 
pPheA [9] using inverse PCR. PCR amplification of the entire plasmid 
was performed with the following 5’-phosphorylated oligonucleotides 
using the ‘Expand long-range PCR’ system (Boehringer Mannheim, 
Germany) in accordance with the manufacturer’s protocol (mutated 
codons are bold and italicized: (1) 3’-A236: B’-ATCAAAAGAGATGCTG- 
GCA-3’; (2) 5’-A236L: 5’-TTATCTGTATGGGAGATGllTATG-3’; (3) 3’- 
W239: 5’-TACAGATGCATCAAAAGAG-3’; (4) 5’-W239G: 5’-GGAGA- 
GATGllTATGGCllTGl-TAAG3’; (5) 5’-W239L: 5’-TTAGAGATGTT- 
TATGGCTTTGTTA-3’; (6) 3’-T278: 5’-AATAACAGTGATTTCCTT- 
T-TGG-3’; (7) 5’-T278M: 5’-ATGCTGCCACCTACCTATGTAG-I-T-3’; (8) 
5’-T278G: 5’-CAGCTGCCACCTACCTATGTAGTT-3’; (9) 3’71299: 5’- 
TAACGTI-TGTATCGATAAAATAC-3’; (10) 5’-1299T: 5’-ACTACAGCA- 
GGCTCAGCTAC3’; (11) 3’-A301 G: 5’-7CCTGTAAlTAACGllTG- 
TATCG-3’; (12) 3’-A301 V: 5’-AACTGTAAlTAACGllTGTATCG-3’; 
(13) 5’-A301: 5’-GGCTCAGCTACCTCGC3’; (14) 3’-A322: 
5’-AATGTAAGl-TACllTCTCCTTG3’; (15) 5’-A322D: 5’-AAGA7TAT- 
GGCCCTACGGAAACA-3’; (16) 5’-A322E: 5’-AATGAATATGGCCC- 
TACGGAAACA-3’; (17) 5’-A322G: 5’-AATGGCTATGGCCCTACGG- 
AAACA-3’; (18) 5’-A3221: 5’-AATAmATGGCCCTACGGAAACA-3’; 
(19) 5’-A322K: 5’-AATAAGTATGGCCCTACGGAAACA-3’; (20) 5’- 
A322N: 5’-AAT?-FGTATGGCCCTACGGAAACA-3’; (21) 5’-A3220 
5’-AATCAGTATGGCCCTACGGAAACA-3’; (22) 5’-A322S: 5’-AAT- 
AGCTATGGCCCTACGGAAACA-3’; (23) 3’-1330: 5’-AGl-f-GllTCCG- 
TAGGGGB’; and (24) 5’-133OV: 5’-G77TGTGCGACTACATGGG-3’. 
PCR products were purified using the ‘QIAquick-spin’ PCR purification 
kit (Qiagen), blunted and intramolecularly ligated in the presence of 
Dpnl. This restriction enzyme requires a methylated recognition site 
and therefore allowed selective decomposition of the PCR template 
pPheA (purified from a dam+ strain). Standard procedures were 
applied for DNA manipulations [36] and the preparation of the recom- 
binant plasmids using Escherichia co/i strain XL1 -Blue [371. Cloning of 
the PCR fragments yielded the plasmids pPheA(A236L) (using 
oligonucleotides 1 and 2), pPheA(W239G) (3 plus 4), pPheA(W239L) 
(3 plus 5) pPheA(T278M) (6 plus 7) pPheA(T278G) (6 plus 8) 
pPheA(l299T) (9 plus lo), pPheA(A301 G) (11 plus 13) pPheA(A3OlV) 
(12 plus 13) pFheA(A322D) (14 plus 15), pPheA(A322E) (14 plus 16) 
pPheA(A322G) (14 plus 17) pPheA(A3221) (14 plus 18) pPheA(A322K) 
(14 plus 19) pPheA(A322N) (14 plus 20) pPheA(A322G) (14 plus 21) 
pPheA(A322S) (14 plus 22) and pPheA(l330V) (23 plus 24). The 
integrity of all constructs was confirmed by sequencing using the ABI 
prism 310 Genetic Analyzer (ABI). 
The DNA fragment encoding the aspartate-activating A domain of SrfA- 
B was PCR amplified from chromosomal DNA of Bacillus subtilis 
JH642 using the oligonucleotides (25) 5’-AspA: 5’-AATCCATGG- 
CGAACGTTCGGCTGTCTG-3’, and (26) 3’-AspA: B’AATGGATC- 
CGGCCAAGGCCTTGCC-3’ [22,30-32,381. The PCR product was 
purified, digested with Ncol and BarnHI, and ligated into the His-tag 
vector pQE60, which was cut in the same manner. Cloning yielded the 
plasmid pAspA, which could then be used as a template for the gener- 
ation of pAspA(H322E) using inverse PCR as described above: (27) 
5’-AspA(H322E): 5’-TAATGAGTACGGCCCGACAGAAGC-3’ (28) 
and 3’-AspA(H322E): 5’-ATAAAlTCGGTATGTCCATAC-3’. The 
integrity of both constructs was confirmed by DNA sequencing. 
Expression and purification of wild-type and mutant A domains 
Expression of the mutant genes and purification of the Hiss-tagged pro- 
teins were carried out as described previously (10,391. Ligating into the 
BamHl site of pGE60 results in appending the amino acid sequence 
‘GSRSHHHHHH’ at the carboxyl terminus of each recombinant 
protein. As judged by SDS-PAGE [40], most proteins could be puri- 
fied to apparent homogeneity using single-step Ni2+-affinity chroma- 
tography; two constructs were insoluble (Table 2). Fractions containing 
the recombinant proteins were pooled and dialyzed against assay 
buffer (50 mM HEPES, pH 8.0, 100 mM sodium chloride, 10 mM mag- 
nesium chloride, 2 mM dithioerythritol (DTE) and 1 mM EDTA). After 
addition of 10% glycerol (w/v), the proteins could be stored at -80°C 
with no observable loss of activity. Protein concentrations were deter- 
mined using the calculated extinction coefficients for their absorbance 
at 280 nm (A280nm ): 64,060 M-1 cm-l for PheA and all PheA mutants 
except PheA(W239Xaa), 58,370 M-l cm-l for PheA(W239Xaa) and 
39,780 M-1 cm-’ for AspA and AspA(H322E). 
ATP-pyrophosphate exchange assay 
The ATP-pyrophosphate exchange reaction was carried out to examine 
the activity and specificity of all recombinant A domains purified [8,10]. 
The specificity was checked with all proteinogenic amino acids, as well 
as L-ornithine and n-phenylalanine. Reaction mixtures contained (final 
volume: 100 ul): 50mM HEPES, pH 8.0, 100 mM sodium chloride, 
10 mM magnesium chloride, 2 mM DTE, 1 mM EDTA, O-2 mM amino 
acid and 250 nM enzyme. The reaction was initiated by the addition of 
2 mM ATP, 0.2 mM tetrasodium pyrophosphate and 0.15 uCi 
(16.06 Cilmmol) of tetrasodium [32P)pyrophosphate (NENIDuPont) and 
incubated at 37% for 10 min. Reactions were quenched by adding 
0.5 ml of a stop mix containing 1.2% (w/v) activated charcoal, 0.1 M 
tetrasodium pyrophosphate and 0.35 M perchloric acid. Subsequently, 
the charcoal was pelleted by centrifugation, washed once with 1 ml 
water and resuspended in 0.5 ml water. After addition of 3.5 ml liquid 
scintillation fluid (Rotiscint Eco Plus; Roth), the charcoal-bound radioac- 
tivity was determined by liquid scintillation counting (LSC) using a 
1900CA Tri-Carb liquid scintillation analyzer (Packard). 
Computer analysis for the determination of putative 
substrate-binding pockets 
The sequences of 160 A domains were retrieved from publicly access- 
able databases (NCBI, Swiss-Prot etc.). After outlining the lOO-aa 
stretches between core motifs A4 and A5, the sequences were aligned 
using the program MegAlign from the DNA Star package, applying the 
Clustal method with default parameters. The only purpose of this step 
was to ease the assessment of the constituents of the proposed 
binding pockets. This goal was achieved by considering their positions 
relative to adjacent, highly conserved core motifs (A4 and A5, as well as 
the two unnamed motifs ‘TPS’ and ‘GE’; structural ‘anchors’). All 
sequences were trimmed to the constituents of their presumed binding 
pockets, and new sequence alignments and phylogenetic studies were 
performed using only these ten residues. Clustering of signature 
sequences according to their specificity was obtained using several 
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methods and sets of parameters. The particular phylogenetic tree 
shown in Figure 3 was constructed as in Hein [41] applying the follow- 
ing parameters: gap penalty 12, gap length penalty 6 and Ktuple 2. 
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